News

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with weight-loss drugmaker Novo Nordisk abruptly ended.
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...
More than 20 million people globally are injecting themselves with GLP-1s... Weight-loss pills will only see that explode ...
The way to shake the way you’re feeling about your friend’s choice,” counsels Eva Wiseman, “is to turn your gaze upon ...
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A knock-on effect from the use Ozempic is a change of diet, including a reliance on caffeine and low carbs. However, this ...
These six stocks span numerous sectors, providing investors with opportunities in both growth and dividend yield.
There are a few potential risks to keep in mind with rice water, including some food safety concerns.
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...
In his new book, a former FDA commissioner unpacks the latest science on metabolism, weight loss, and how GLP-1 drugs ...